GD2 Antibody (Naxitamab)
1 clinical trials · Condition
◉ Watch GD2 Antibody (Naxitamab)
| Record | Firm | Date |
|---|---|---|
| Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma (NCT06574698) | Guangzhou Women and Children's Medical Center | 2024-05-06 |
Track GD2 Antibody (Naxitamab) automatically
Every clearance here is in the API, with alerts when new ones post.